ANI Pharmaceuticals (ANIP) Stock Price, Quote, News & History | Benzinga

ANI Pharmaceuticals Inc (ANIP) Stock Price, Quote, News & History

ANIPNASDAQ

Trade with Public

Trade with Public

$73.50

-1.06-1.42%

Last update: Aug 27, 9:28 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$73.58

Close

-

Volume / Avg.

95.36K / 343.05K

Day Range

$73.24 - $74.50

52 Wk Range

70.15 - 99.50

Market Cap

$1.69B

P/E Ratio

16.24

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

18.14%

Days to Cover

7.37

Recent ANI Pharmaceuticals, Inc. News

These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results

ANI Pharmaceuticals Inc (NASDAQ:ANIP) reported strong Q2 earnings, affirmed FY2026 guidance, and saw changes in price targets by analysts.

Avi Kapoor

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.

Stjepan Kalinic

ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50%

ANI Pharma beats Q4 estimates, swings to profit, and sees over $1 billion in 2026 sales as Rare Disease revenue surges 50%.

Vandana Singh

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

Avi Kapoor

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

ANI Pharmaceuticals Q1 revenue rose 43.4% to $197.12 million, EPS beat consensus, and 2025 guidance was raised on strong Cortrophin Gel and generics growth.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

189.47M

Investing Cash Flow (TTM)

-21.94M

Financing Cash Flow (TTM)

-24.55M

Free Cash Flow (TTM)

167.52M

Capital Expenditure (TTM)

-21.94M

Net Change in Cash (TTM)

142.97M

Analyst Trends and Forecast

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.95B

PE Ratio (TTM)

16.24

PE Ratio (FWD)

8.45

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.68

PB Ratio (TTM)

2.87

Earnings Yield % (TTM)

6.16%

Earnings Yield % (FWD)

11.83%

EV / EBITDA (TTM)

7.95

Price / EBITDA (TTM)

6.70

Price / Free Cash Flow (TTM)

9.80

Book Value / Share

$26.00

Company Debt

Total Debt

$610.49M

LT Debt

$589.16M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$14.22M

Total Cash

$360.21M

Debt to Equity

1.02

Issuance of Debt (TTM)

-$14.22M

Repayment of Debt (TTM)

-$14.22M

Key Statistics

Open

$73.58

Close

-

Volume / Avg.

95.36K / 343.05K

Day Range

$73.24 - $74.50

52 Wk Range

70.15 - 99.50

Market Cap

$1.69B

P/E Ratio

16.24

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

18.14%

Days to Cover

7.37

About

Sector

Health Care

Industry

Pharmaceuticals

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatolo...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy ANI Pharmaceuticals (ANIP) stock?

A

You can purchase shares of ANI Pharmaceuticals (NASDAQ:ANIP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ANI Pharmaceuticals (ANIP) competitors?

A

Other companies in ANI Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for ANI Pharmaceuticals (ANIP) stock?

A

ANI Pharmaceuticals has a consensus price target of $94.55.

Q

What is the current price for ANI Pharmaceuticals (ANIP)?

A

The stock price for ANI Pharmaceuticals (NASDAQ: ANIP) is $73.5 last updated August 27, 2026 at 9:28 AM EDT.

Q

Does ANI Pharmaceuticals (ANIP) pay a dividend?

A

There are no upcoming dividends for ANI Pharmaceuticals.

Q

When is ANI Pharmaceuticals (NASDAQ:ANIP) reporting earnings?

A

ANI Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is ANI Pharmaceuticals (ANIP) going to split?

A

There is no upcoming split for ANI Pharmaceuticals.

Q

What sector and industry does ANI Pharmaceuticals (ANIP) operate in?

A

ANI Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.